Subject
Editions published in Neurodegenerative disease management 404
-
Using biomarkers to improve detection of Alzheimer's disease.
-
Promoting exercise in Parkinson's disease through community-based participatory research
-
Depression in the early stages of Huntington disease
-
The role of exercise in facilitating basal ganglia function in Parkinson's disease
-
Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options
-
Role of vitamin D in multiple sclerosis: implications for disease management
-
ABCA1, apoE and apoA-I as potential therapeutic targets for treating Alzheimer’s disease
-
Is modulating translation a therapeutic option for Huntington's disease?
-
Physiotherapy clinical guidelines for Huntington’s disease
-
Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review
-
OPTIMIZING DIAGNOSIS AND MANANGEMENT IN MILD-TO-MODERATE ALZHEIMER'S DISEASE.
-
Essential tremor is not a neurodegenerative disease
-
Monitoring Huntington's disease progression through preclinical and early stages
-
How predictive of dementia are peripheral inflammatory markers in the elderly?
-
Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?
-
Impulse control disorders in Parkinson's disease: background and update on prevention and management
-
Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease
-
Do women with Alzheimer’s disease demonstrate greater cognitive deterioration?
-
The Role of Parkin in Parkinson's Disease: a stem cell perspective
-
Current guidelines for dementia screening: shortcomings and recommended changes
-
Depressive Symptoms in Clinical and Incipient Alzheimer's Disease
-
Should we disclose amyloid imaging results to cognitively normal individuals?
-
Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues
-
Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment
-
Managing juvenile Huntington's disease
-
IPX066: a new intermediate-and extended-release carbidopa-levodopa formulation
-
Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of neurodegenerative disease management
-
Journal Watch: Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of neurodegenerative disease management
-
Are inflammatory profiles the key to personalized Alzheimer's treatment?
-
Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs
-
Managing depression in Parkinson's patients: risk factors and clinical pearls
-
The sleep-wake cycle and Alzheimer's disease: what do we know?
Subject -